SCHEMBL1474380

SCHEMBL1474380

Cc1cccc(CCNC(=O)c2cc(-c3ccco3)on2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.77
NPC1 O15118 7/20 0.77
RAB9A P51151 7/20 0.77
SMN1; SMN2 Q16637 6/20 0.77
HTT P42858 4/20 0.69
MAPT P10636 3/20 0.69
LMNA P02545 2/20 0.69
HPGD P15428 4/20 0.67
GAA P10253 2/20 0.67
TP53 P04637 1/20 0.67
KMT2A Q03164 7/20 0.57
MEN1 O00255 5/20 0.57
KDM4E B2RXH2 3/20 0.57
PKM P14618 1/20 0.57
HSD17B10 Q99714 2/20 0.57
MAPK1 P28482 1/20 0.56
CASP3 P42574 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
TSHR P16473 2/20 0.54
FAAH O00519 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1476447 0.89 ALDH1A1 (0.80) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1475343 0.88 ALDH1A1 (0.79) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1474855 0.87 NPC1 (1.00) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1474632 0.87 ALDH1A1 (0.77) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1475213 0.86 ALDH1A1 (0.74) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1474487 0.83 ALDH1A1 (0.75) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL15190158 0.83 ALDH1A1 (0.53) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1178320 0.83 ALDH1A1 (0.82) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1474866 0.83 ALDH1A1 (0.82) ALDH1A1NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1178360 0.82 NPC1 (0.80) ALDH1A1NPC1RAB9ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 ALDH1A1 706/4885NPC1 2242/4885RAB9A 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.